Target intelligence / Profile preview

Protein naked cuticle homolog 2 (NKD2)

Target
NKD2
Molecular classification
Other (Wnt signaling pathway inhibitor), Vesicle trafficking adaptor protein, Intrinsically unstructured protein
01

Overview

Protein naked cuticle homolog 2 (NKD2) is a protein encoded by the NKD2 gene in humans and is part of the Naked cuticle family, primarily recognized as a negative regulator of the canonical Wnt signaling pathway through its interaction with Dishevelled family proteins (DVL1, DVL2, DVL3)[1][3]. Unlike its close homolog NKD1, NKD2 also binds transforming growth factor alpha (TGFα) and functions as a basolateral sorting adaptor, guiding TGFα-containing secretory vesicles to the basolateral membrane of polarized epithelial cells, a process dependent on N-terminal myristoylation[1][2][6]. The protein is predominantly intrinsically unstructured, with most functional domains—such as the Dishevelled-binding region, EF-hand-like motif, and vesicle recognition motif—located in the N-terminal half[2]. NKD2’s regulatory role in Wnt signaling connects it to processes controlling stem cell self-renewal and tumorigenesis, with increased interest regarding its altered expression in several cancers (such as osteosarcoma)[5]. No direct interacting drugs or approved therapeutic targeting currently exist, but the modulation of Wnt pathway activity by NKD2 underlies its importance as a potential biomarker and future therapeutic target[3].

Other names
Naked-2hNkd2Naked2naked cuticle-2Dvl-binding protein NKD2NKD inhibitor of Wnt signaling pathway 2WNT signaling pathway inhibitornaked cuticle homolog 2
02

Biological functions

Negative regulation of Wnt signalingProtein-protein interaction with Dishevelled (DVL) proteinsRegulated trafficking of transforming growth factor alpha (TGFα)-containing vesiclesSignal transduction
03

Disease associations

Cancer (e.g., implicated as a biomarker in osteosarcoma)Other (modulator of cell polarity relevant for epithelial homeostasis and potentially tumorigenesis)
04

Biomarkers

NKD2 expression as a prognostic and progression marker in osteosarcoma

Beyond the preview

Go deeper on Protein naked cuticle homolog 2 (NKD2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Protein naked cuticle homolog 2 (NKD2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call